|
TCP11L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.763400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.122130E-02 |
| Normal-vs-Stage2 |
5.744800E-01 |
| Normal-vs-Stage3 |
1.568410E-01 |
| Normal-vs-Stage4 |
8.015600E-03 |
| Stage1-vs-Stage2 |
2.976200E-01 |
| Stage1-vs-Stage3 |
5.72409999999302E-05 |
| Stage1-vs-Stage4 |
6.24889999967237E-07 |
| Stage2-vs-Stage3 |
1.402840E-01 |
| Stage2-vs-Stage4 |
1.297650E-02 |
| Stage3-vs-Stage4 |
1.435560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.987800E-01 |
| Normal-vs-AfricanAmerican |
3.297200E-01 |
| Normal-vs-Asian |
3.447000E-01 |
| Caucasian-vs-AfricanAmerican |
9.921500E-02 |
| Caucasian-vs-Asian |
6.587000E-01 |
| AfricanAmerican-vs-Asian |
3.362800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.665200E-01 |
| Normal-vs-Female |
4.009000E-01 |
| Male-vs-Female |
5.171600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.359400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.217640E-01 |
| Normal-vs-Age(61-80Yrs) |
7.636800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.330000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.381600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.455400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.706000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.990200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.136100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.181000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.707210E-01 |
| Normal-vs-Grade 2 |
2.238300E-02 |
| Normal-vs-Grade 3 |
8.089400E-01 |
| Normal-vs-Grade 4 |
2.986800E-04 |
| Grade 1-vs-Grade 2 |
4.710800E-01 |
| Grade 1-vs-Grade 3 |
8.128200E-02 |
| Grade 1-vs-Grade 4 |
1.303570E-02 |
| Grade 2-vs-Grade 3 |
7.561600E-03 |
| Grade 2-vs-Grade 4 |
7.0876999824776E-09 |
| Grade 3-vs-Grade 4 |
3.036400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.216100E-03 |
| Normal-vs-ccB subtype |
4.416400E-01 |
| ccA subtype-vs-ccB subtype |
2.613500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.409600E-01 |
| Normal-vs-N1 |
1.151200E-01 |
| N0-vs-N1 |
5.417900E-02 |
|
|
